PROFILPELAJAR.COM

Orifarm

Orifarm Group A/S
Formation1994
FounderBrigitte and Hans Bøgh-Sørensen
HeadquartersOdense, Denmark
SubsidiariesPilatus Comparator Solutions
Websitewww.orifarm.com

Orifarm (founded 1994) is a Danish pharmaceutical company[1][2] based in Odense.[3][4][5]

History

Orifarm is a family-owned company established in 1994 by Hans Bøgh-Sørensen and his wife Birgitte Bøgh-Sørensen.[6][7]

Orifarm entered the market in 1995 with a portfolio of 25 products and 9 employees. Since then, the company has experienced significant growth and currently employs approximately 2,200 persons across multiple locations in Europe and the United States.[8]

In 1997, Orifarm expanded into Sweden, marking its first presence in a European market beyond Denmark. By 2014, Orifarm entered the Dutch market, establishing its sixth sales office in Europe.[9][10]

In 2019, Orifarm extended its operations beyond Europe by acquiring Pilatus Comparator Solutions, a company active in the United Kingdom, Germany, and the United States.[11]

In 2020, the company bought a part of Takeda Pharmaceutical Company (Japan) and the[3][12][13] rights to a number of over-the-counter and prescription medicines for DKK 4.6 billion (670 million USD).[14][15] Through this acquisition, Orifarm also gained control of two production facilities in Łyszkowice, Poland, and Hobro, Denmark.[16]

In 2021, the company’s revenue increased by 27% to DKK 10.54 billion (EUR 1,417 billion). Operating profit also rose by 39%, reaching DKK 413 million (EUR 55.3 million).[17]

References

  1. ^ "101 Top Health Care Startups and Companies in Denmark (2021)".
  2. ^ "PIL error: Orifarm Concerta XL | Dispensing Doctor Association". www.dispensingdoctor.org. Retrieved 2024-03-26.
  3. ^ a b Tirumalaraju, Divya (2020-04-24). "Takeda to sell OTC and non-core assets to Orifarm for $670m". Pharmaceutical Technology. Retrieved 2024-03-26.
  4. ^ "Information management platform startup M-Files raises $80M". SiliconANGLE. 2021-01-12. Retrieved 2024-03-26.
  5. ^ "Takeda Sells OTC Drugs to Denmark's Orifarm | CHEManager". www.chemanager-online.com. Retrieved 2024-03-26.
  6. ^ "The year our onboarding reached new heights - Orifarm". www.orifarm.com. Retrieved 2024-03-26.
  7. ^ "How an acquisition helped Orifarm prepare a prescription for growth". www.ey.com. Retrieved 2024-03-26.
  8. ^ "Orifarm ansætter flere og bygger nyt: Milliard-opkøb af japansk gigant var en større mundfuld end ventet | fyens.dk". fyens.dk (in Danish). 2022-04-19. Retrieved 2024-07-01.
  9. ^ "How an acquisition helped Orifarm prepare a prescription for growth". www.ey.com. Retrieved 2024-03-26.
  10. ^ "Ny direktør bestod: Fynske Orifarm har aldrig tjent mere | fyens.dk". fyens.dk (in Danish). 2019-05-29. Retrieved 2024-03-26.
  11. ^ "Orifarm has high hopes for new business arm - may be the key to the US market". medwatch.dk (in Danish). 2020-03-25. Retrieved 2024-07-01.
  12. ^ Nawrat, Allie (2020-04-28). "Takeda-Orifarm deal: another divestiture for the Japanese pharma giant". Pharmaceutical Technology. Retrieved 2024-03-26.
  13. ^ Wessel, Lene (2022-06-10). "HR-direktør om onboarding af 900 medarbejdere: "Hold øje med de bløde ting" | PeopleTech (PRO)". ing.dk (in Danish). Retrieved 2024-03-26.
  14. ^ "Konkurrencerådet griber ind i Orifarms overtagelse af dele af Takeda". www.kfst.dk (in Danish). 2021-03-24. Retrieved 2024-03-26.
  15. ^ "Large multimillion Euro acquisition - Orifarm". www.orifarm.com. Retrieved 2024-03-26.
  16. ^ "Orifarm køber lægemidler og fabrikker af Takeda for 4,6 mia. kr". medwatch.dk (in Danish). 2020-04-24. Retrieved 2024-07-01.
  17. ^ "Orifarm i stor fremgang - omsætningen runder 10 mia. kr". medwatch.dk (in Danish). 2022-07-04. Retrieved 2024-07-01.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.